REGULATED PRESS RELEASE published on 04/09/2024 at 07:15, 1 year 7 months ago bioMérieux presents its new 5-year strategic plan and its targets for profitable growth bioMérieux unveils its 5-year strategic plan, GO•28, aimed at sustainable growth and responsiblity. Targets include +7% organic revenue growth and -50% GHG emissions by 2030 BioMérieux Strategic Plan Organic Growth GHG Emissions GO•28
REGULATED PRESS RELEASE published on 04/09/2024 at 07:15, 1 year 7 months ago bioMérieux présente son nouveau plan stratégique à 5 ans et son objectif de croissance rentable bioMérieux présente son nouveau plan stratégique GO•28 visant une croissance rentable et durable pour les 5 prochaines années BioMérieux Plan Stratégique Diagnostic In Vitro Croissance Rentable GO•28
BRIEF published on 04/09/2024 at 07:06, 1 year 7 months ago BioMérieux annonce une croissance robuste au premier trimestre 2024 BioMérieux Diagnostic In Vitro Croissance Des Ventes BIOFIRE SPOTFIRE
BRIEF published on 04/09/2024 at 07:06, 1 year 7 months ago BioMérieux Posts Strong First-Quarter 2024 Results with Outstanding Sales Growth BioMérieux In Vitro Diagnostics First-Quarter 2024 BIOFIRE® Panels SPOTFIRE®
REGULATED PRESS RELEASE published on 04/09/2024 at 07:01, 1 year 7 months ago bioMérieux – Information financière du 1er trimestre 2024 bioMérieux a annoncé des ventes en forte croissance de +10% au 1er trimestre 2024, portées par le succès des panels BIOFIRE® et de la solution SPOTFIRE® Croissance BioMérieux Ventes Panels BIOFIRE® Solution SPOTFIRE®
REGULATED PRESS RELEASE published on 04/09/2024 at 07:01, 1 year 7 months ago bioMérieux – First-Quarter 2024 Business Review bioMérieux reports strong +10% organic sales growth in the first quarter of 2024, driven by BIOFIRE® and microbiology segments. Sales reach €965 million. Company confirms 2024 guidance for sales and operating profit BioMérieux Organic Sales Growth 2024 Guidance BIOFIRE® Microbiology
BRIEF published on 04/05/2024 at 09:04, 1 year 8 months ago BioMérieux annonce son nombre d’actions et de droits de vote pour mars 2024 Droits De Vote Capital Social BioMérieux Actions Mars 2024
BRIEF published on 04/05/2024 at 09:04, 1 year 8 months ago BioMérieux announces its number of shares and voting rights for March 2024 Share Capital Voting Rights BioMérieux Actions March 2024
REGULATED PRESS RELEASE published on 04/05/2024 at 08:59, 1 year 8 months ago Mars 2024 - Déclaration sur le nombre d'actions composant le capital social et le nombre de droits de vote correspondant bioMérieux communique les informations mensuelles relatives au nombre total de droits de vote et d'actions au 31/03/2024 Droits De Vote Code De Commerce BioMérieux Actions Informations Mensuelles
BRIEF published on 04/05/2024 at 07:06, 1 year 8 months ago BioMérieux and Mérieux NutriSciences Launch Collaborative Data-Driven Initiative for Food Safety BioMérieux Food Safety Industry Collaboration Data-driven Initiative Consumer Safety
Published on 12/05/2025 at 21:45, 18 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 33 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 43 minutes ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 3 minutes ago The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 38 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 18:58, 3 hours 5 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 3 hours 47 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 4 hours 16 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 4 hours 45 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 45 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 52 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 52 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 4 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
